CoChat
Sign Up
Cited by 74

Targeting Microglial Activation in Stroke Therapy: Pharmacological Tools and Gender Effects

Chen, Y., Won, S.J., Xu, Y., Swanson, R.A.·2014·Current Medicinal Chemistry
DOI 10.2174/0929867321666131228203906PMC PMC4076056
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/0929867321666131228203906

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 123

  1. [1]Ginsberg MD Neuroprotection for ischemic stroke: past, present and future Neuropharmacology 2008 55 3 363 389 18308347 PMC2631228
  2. [2]Dirnagl U Iadecola C Moskowitz MA Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 1999 22 9 391 397 10441299
  3. [3]Kreutzberg GW Microglia: a sensor for pathological events in the CNS Trends Neurosci 1996 19 8 312 318 8843599
  4. [5]Stoll G Jander S Schroeter M Inflammation and glial responses in ischemic brain lesions Prog Neurobiol 1998 56 2 149 171 9760699
  5. [6]del Zoppo GJ Frankowski H Gu YH Osada T Kanazawa M Milner R Wang X Hosomi N Mabuchi T Koziol JA Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation J Cereb Blood Flow Metab 2012 32 5 919 932 22354151 PMC3345906
  6. [8]Yenari MA Xu L Tang XN Qiao Y Giffard RG Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro Stroke 2006 37 4 1087 1093 16497985
  7. [9]Yenari MA Kauppinen TM Swanson RA Microglial activation in stroke: therapeutic targets Neurotherapeutics 2010 7 4 378 391 20880502 PMC5084300
  8. [10]Subramanian S Zhang B Kosaka Y Burrows GG Grafe MR Vandenbark AA Hurn PD Offner H Recombinant T cell receptor ligand treats experimental stroke Stroke 2009 40 7 2539 2545 19443805 PMC2704258
  9. [11]Gelderblom M Weymar A Bernreuther C Velden J Arunachalam P Steinbach K Orthey E Arumugam TV Leypoldt F Simova O Thom V Friese MA Prinz I Holscher C Glatzel M Korn T Gerloff C Tolosa E Magnus T Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke Blood 2012 120 18 3793 3802 22976954
  10. [12]McColl BW Rothwell NJ Allan SM Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin- 1- and neutrophil-dependent mechanisms J Neurosci 2007 27 16 4403 4412 17442825 PMC6672305
  11. [13]Chamorro A Meisel A Planas AM Urra X van de Beek D Veltkamp R The immunology of acute stroke Nat Rev Neurol 2012 8 7 401 410 22664787
  12. [14]Ren X Akiyoshi K Dziennis S Vandenbark AA Herson PS Hurn PD Offner H Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke J Neurosci 2011 31 23 8556 8563 21653859 PMC3111929
  13. [15]Iadecola C Anrather J The immunology of stroke: from mechanisms to translation Nat Med 2011 17 7 796 808 21738161 PMC3137275
  14. [16]Glass CK Saijo K Winner B Marchetto MC Gage FH Mechanisms underlying inflammation in neurodegeneration Cell 2010 140 6 918 934 20303880 PMC2873093
  15. [18]Zhang Z Artelt M Burnet M Schluesener HJ Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury Acta Neuropathol 2007 113 6 675 682 17265048
  16. [19]Sugama S Takenouchi T Fujita M Kitani H Conti B Hashimoto M Corticosteroids limit microglial activation occurring during acute stress Neuroscience 2012 232C 13 20 23262242
  17. [20]McRae A Bona E Hagberg H Microglia-astrocyte interactions after cortisone treatment in a neonatal hypoxia-ischemia model Brain Res Dev Brain Res 1996 94 1 44 51 8816276
  18. [21]Sapolsky RM Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion Stress 1996 1 1 1 19 9807058
  19. [23]Sorrells SF Sapolsky RM An inflammatory review of glucocorticoid actions in the CNS Brain Behav Immun 2007 21 3 259 272 17194565 PMC1997278
  20. [24]Sandercock PA Soane T Corticosteroids for acute ischaemic stroke Cochrane Database Syst Rev 2011 9 CD000064 21901674 PMC7032681
  21. [25]Hoehn BD Palmer TD Steinberg GK Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin Stroke 2005 36 12 2718 2724 16282546
  22. [26]Krishnakumar R Kraus WL The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets Mol Cell 2010 39 1 8 24 20603072 PMC2923840
  23. [27]Ji Y Tulin AV The roles of PARP1 in gene control and cell differentiation Curr Opin Genet Dev 2010 20 5 512 518 20591646 PMC2942995
  24. [28]Chiarugi A Moskowitz MA Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders J Neurochem 2003 85 2 306 317 12675907
  25. [29]Ha HC Hester LD Snyder SH Poly(ADP-ribose) polymerase- 1 dependence of stress-induced transcription factors and associated gene expression in glia Proc Natl Acad Sci U S A 2002 99 5 3270 3275 11854472 PMC122508
  26. [30]Kummar S Ji J Morgan R Lenz HJ Puhalla SL Belani CP Gandara DR Allen D Kiesel B Beumer JH Newman EM Rubinstein L Chen A Zhang Y Wang L Kinders RJ Parchment RE Tomaszewski JE Doroshow JH A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas Clin Cancer Res 2012 18 6 1726 1734 22307137 PMC3306481
  27. [31]Kauppinen TM Swanson RA Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase- 9-mediated neuron death J Immunol 2005 174 4 2288 2296 15699164
  28. [32]Hamby AM Suh SW Kauppinen TM Swanson RA Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion Stroke 2007 38 2 Suppl 632 636 17261705
  29. [33]Kauppinen TM Suh SW Berman AE Hamby AM Swanson RA Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury J Cereb Blood Flow Metab 2009 29 4 820 829 19190653
  30. [34]Endres M Wang ZQ Namura S Waeber C Moskowitz MA Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase J Cereb Blood Flow Metab 1997 17 11 1143 1151 9390645
  31. [35]Takahashi K Greenberg JH Jackson P Maclin K Zhang J Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats J Cereb Blood Flow Metab 1997 17 11 1137 1142 9390644
  32. [36]Koh DW Dawson TM Dawson VL Mediation of cell death by poly(ADP-ribose) polymerase-1 Pharmacol Res 2005 52 1 5 14 15911329
  33. [38]Yrjanheikki J Tikka T Keinanen R Goldsteins G Chan PH Koistinaho J A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci U S A 1999 96 23 13496 13500 10557349 PMC23976
  34. [39]Tikka TM Koistinaho JE Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia J Immunol 2001 166 12 7527 7533 11390507
  35. [40]Suk K Minocycline suppresses hypoxic activation of rodent microglia in culture Neurosci Lett 2004 366 2 167 171 15276240
  36. [42]Yrjanheikki J Keinanen R Pellikka M Hokfelt T Koistinaho J Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc Natl Acad Sci U S A 1998 95 26 15769 15774 9861045 PMC28119
  37. [43]Wixey JA Reinebrant HE Carty ML Buller KM Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain J Neuroimmunol 2009 212 1–2 35 43 19447505
  38. [44]Wixey JA Reinebrant HE Spencer SJ Buller KM Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain Neuroscience 2011 182 184 192 21440046
  39. [45]Arvin KL Han BH Du Y Lin SZ Paul SM Holtzman DM Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury Ann Neurol 2002 52 1 54 61 12112047
  40. [46]Xu L Fagan SC Waller JL Edwards D Borlongan CV Zheng J Hill WD Feuerstein G Hess DC Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats BMC Neurol 2004 4 7 15109399 PMC415551
  41. [47]Jiang SX Lertvorachon J Hou ST Konishi Y Webster J Mealing G Brunette E Tauskela J Preston E Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia J Biol Chem 2005 280 40 33811 33818 16091365
  42. [48]Wang J Wei Q Wang CY Hill WD Hess DC Dong Z Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria J Biol Chem 2004 279 19 19948 19954 15004018
  43. [49]Fernandez-Gomez FJ Galindo MF Gomez-Lazaro M Gonzalez-Garcia C Cena V Aguirre N Jordan J Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions Neuroscience 2005 133 4 959 967 15964487
  44. [50]Zhu S Stavrovskaya IG Drozda M Kim BY Ona V Li M Sarang S Liu AS Hartley DM Wu DC Gullans S Ferrante RJ Przedborski S Kristal BS Friedlander RM Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 2002 417 6884 74 78 11986668
  45. [51]Wang X Zhu S Drozda M Zhang W Stavrovskaya IG Cattaneo E Ferrante RJ Kristal BS Friedlander RM Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington’s disease Proc Natl Acad Sci U S A 2003 100 18 10483 10487 12930891 PMC193587
  46. [52]Kraus RL Pasieczny R Lariosa-Willingham K Turner MS Jiang A Trauger JW Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radicalscavenging activity J Neurochem 2005 94 3 819 827 16033424
  47. [53]Nikodemova M Duncan ID Watters JJ Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia J Neurochem 2006 96 2 314 323 16336636
  48. [54]Pi R Li W Lee NT Chan HH Pu Y Chan LN Sucher NJ Chang DC Li M Han Y Minocycline prevents glutamate- induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways J Neurochem 2004 91 5 1219 1230 15569265
  49. [55]Alano CC Kauppinen TM Valls AV Swanson RA Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations Proc Natl Acad Sci U S A 2006 103 25 9685 9690 16769901 PMC1480467
  50. [56]Hayakawa K Mishima K Nozako M Hazekawa M Mishima S Fujioka M Orito K Egashira N Iwasaki K Fujiwara M Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism Stroke 2008 39 3 951 958 18258837
  51. [57]Liu Z Fan Y Won SJ Neumann M Hu D Zhou L Weinstein PR Liu J Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia Stroke 2007 38 1 146 152 17122429
  52. [58]Fagan SC Waller JL Nichols FT Edwards DJ Pettigrew LC Clark WM Hall CE Switzer JA Ergul A Hess DC Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study Stroke 2010 41 10 2283 2287 20705929 PMC3916214
  53. [59]Lampl Y Boaz M Gilad R Lorberboym M Dabby R Rapoport A Anca-Hershkowitz M Sadeh M Minocycline treatment in acute stroke: an open-label, evaluator-blinded study Neurology 2007 69 14 1404 1410 17909152
  54. [60]Thiagalingam S Cheng KH Lee HJ Mineva N Thiagalingam A Ponte JF Histone deacetylases: unique players in shaping the epigenetic histone code Ann N Y Acad Sci 2003 983 84 100 12724214
  55. [61]Matsuoka H Fujimura T Hayashi M Matsuda K Ishii Y Aramori I Mutoh S Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression Biochem Pharmacol 2007 74 3 465 476 17559812
  56. [62]Georgopoulos K From immunity to tolerance through HDAC Nat Immunol 2009 10 1 13 14 19088734
  57. [63]Grausenburger R Bilic I Boucheron N Zupkovitz G El-Housseiny L Tschismarov R Zhang Y Rembold M Gaisberger M Hartl A Epstein MM Matthias P Seiser C Ellmeier W Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production J Immunol 2010 185 6 3489 3497 20702731 PMC3175530
  58. [64]Lundh M Christensen DP Rasmussen DN Mascagni P Dinarello CA Billestrup N Grunnet LG Mandrup-Poulsen T Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines Diabetologia 2010 53 12 2569 2578 20878317
  59. [65]Marumo T Hishikawa K Yoshikawa M Hirahashi J Kawachi S Fujita T Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury Am J Physiol Renal Physiol 2010 298 1 F133 141 19906951
  60. [66]Ito K Hanazawa T Tomita K Barnes PJ Adcock IM Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration Biochem Bioph Res Co 2004 315 1 240 245 15013452
  61. [67]Faraco G Pittelli M Cavone L Fossati S Porcu M Mascagni P Fossati G Moroni F Chiarugi A Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo Neurobiol Dis 2009 36 2 269 279 19635561
  62. [68]Chuang DM Leng Y Marinova Z Kim HJ Chiu CT Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci 2009 32 11 591 601 19775759 PMC2771446
  63. [69]Gibson CL Murphy SP Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies J Neurochem 2010 115 4 806 813 20831615 PMC3062975
  64. [70]Faraco G Pancani T Formentini L Mascagni P Fossati G Leoni F Moroni F Chiarugi A Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain Mol Pharmacol 2006 70 6 1876 1884 16946032
  65. [71]Ren M Leng Y Jeong M Leeds PR Chuang DM Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction J Neurochem 2004 89 6 1358 1367 15189338
  66. [72]Kim HJ Rowe M Ren M Hong JS Chen PS Chuang DM Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action J Pharmacol Exp Ther 2007 321 3 892 901 17371805
  67. [73]Vecsey CG Hawk JD Lattal KM Stein JM Fabian SA Attner MA Cabrera SM McDonough CB Brindle PK Abel T Wood MA Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation J Neurosci 2007 27 23 6128 6140 17553985 PMC2925045
  68. [74]Guan JS Haggarty SJ Giacometti E Dannenberg JH Joseph N Gao J Nieland TJ Zhou Y Wang X Mazitschek R Bradner JE DePinho RA Jaenisch R Tsai LH HDAC2 negatively regulates memory formation and synaptic plasticity Nature 2009 459 7243 55 60 19424149 PMC3498958
  69. [75]Kim MS Akhtar MW Adachi M Mahgoub M Bassel-Duby R Kavalali ET Olson EN Monteggia LM An essential role for histone deacetylase 4 in synaptic plasticity and memory formation J Neurosci 2012 32 32 10879 10886 22875922 PMC3480333
  70. [76]Bardai FH D’Mello SR Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta J Neurosci 2011 31 5 1746 1751 21289184 PMC3711464
  71. [77]Kazantsev AG Thompson LM Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat Rev Drug Discov 2008 7 10 854 868 18827828
  72. [78]Lehnardt S Lehmann S Kaul D Tschimmel K Hoffmann O Cho S Krueger C Nitsch R Meisel A Weber JR Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia J Neuroimmunol 2007 190 1–2 28 33 17854911
  73. [79]Brea D Blanco M Ramos-Cabrer P Moldes O Arias S Perez-Mato M Leira R Sobrino T Castillo J Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values J Cereb Blood Flow Metab 2011 31 6 1424 1431 21206505 PMC3130315
  74. [80]Abe T Shimamura M Jackman K Kurinami H Anrather J Zhou P Iadecola C Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia Stroke 2010 41 5 898 904 20360550 PMC2950279
  75. [81]Kunz A Abe T Hochrainer K Shimamura M Anrather J Racchumi G Zhou P Iadecola C Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion J Neurosci 2008 28 7 1649 1658 18272685 PMC2588435
  76. [82]Cho S Park EM Febbraio M Anrather J Park L Racchumi G Silverstein RL Iadecola C The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia J Neurosci 2005 25 10 2504 2512 15758158 PMC6725161
  77. [83]Cho S Szeto HH Kim E Kim H Tolhurst AT Pinto JT A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36 J Biol Chem 2007 282 7 4634 4642 17178711
  78. [84]Gregersen R Lambertsen K Finsen B Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice J Cereb Blood Flow Metab 2000 20 1 53 65 10616793
  79. [85]Botchkina GI Meistrell ME 3rd Botchkina IL Tracey KJ Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia Mol Med 1997 3 11 765 781 9407552 PMC2230243
  80. [86]Shohami E Ginis I Hallenbeck JM Dual role of tumor necrosis factor alpha in brain injury Cytokine Growth Factor Rev 1999 10 2 119 130 10743503
  81. [87]Yoon JS Lee JH Tweedie D Mughal MR Chigurupati S Greig NH Mattson MP 3,6′-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation J Neurosci Res 2013 91 5 671 680 23404341 PMC4807430
  82. [88]Hosomi N Ban CR Naya T Takahashi T Guo P Song XY Kohno M Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia J Cereb Blood Flow Metab 2005 25 8 959 967 15729288
  83. [89]Lavine SD Hofman FM Zlokovic BV Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury J Cereb Blood Flow Metab 1998 18 1 52 58 9428305
  84. [90]Barone FC Arvin B White RF Miller A Webb CL Willette RN Lysko PG Feuerstein GZ Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury Stroke 1997 28 6 1233 1244 9183357
  85. [91]Sumbria RK Boado RJ Pardridge WM Brain protection from stroke with intravenous TNFalpha decoy receptor-Trojan horse fusion protein J Cereb Blood Flow Metab 2012 32 10 1933 1938 22714051 PMC3463885
  86. [92]Heldmann U Thored P Claasen JH Arvidsson A Kokaia Z Lindvall O TNF-alpha antibody infusion impairs survival of stroke-generated neuroblasts in adult rat brain Exp Neurol 2005 196 1 204 208 16157335
  87. [93]McCoy MK Tansey MG TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease J Neuroinflammation 2008 5 45 18925972 PMC2577641
  88. [94]Hurn PD Macrae IM Estrogen as a neuroprotectant in stroke J Cereb Blood Flow Metab 2000 20 4 631 652 10779008
  89. [95]Yuan M Siegel C Zeng Z Li J Liu F McCullough LD Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke Exp Neurol 2009 217 1 210 218 19268668 PMC2672307
  90. [96]Roof RL Hall ED Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone J Neurotrauma 2000 17 5 367 388 10833057
  91. [98]Schwarz JM Sholar PW Bilbo SD Sex differences in microglial colonization of the developing rat brain J Neurochem 2012 120 6 948 963 22182318 PMC3296888
  92. [99]Elzer JG Muhammad S Wintermantel TM Regnier-Vigouroux A Ludwig J Schutz G Schwaninger M Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol J Cereb Blood Flow Metab 2010 30 5 935 942 20010956 PMC2949189
  93. [100]Arevalo MA Santos-Galindo M Acaz-Fonseca E Azcoitia I Garcia-Segura LM Gonadal hormones and the control of reactive gliosis Horm Behav 2013 63 2 216 221 22401743
  94. [101]Bruce-Keller AJ Keeling JL Keller JN Huang FF Camondola S Mattson MP Antiinflammatory effects of estrogen on microglial activation Endocrinology 2000 141 10 3646 3656 11014219
  95. [102]Mann SA Versmold B Marx R Stahlhofen S Dietzel ID Heumann R Berger R Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats J Neuroinflammation 2008 5 39 18808689 PMC2562366
  96. [103]Du L Bayir H Lai Y Zhang X Kochanek PM Watkins SC Graham SH Clark RS Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway J Biol Chem 2004 279 37 38563 38570 15234982
  97. [104]Jiang C Cui K Wang J He Y Microglia and cyclooxygenase- 2: possible therapeutic targets of progesterone for stroke Int Immunopharmacol 2011 11 11 1925 1931 21843661
  98. [105]Muller E Kerschbaum HH Progesterone and its metabolites 5- dihydroprogesterone and 5–3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2 Neuro Endocrinol Lett 2006 27 5 675 678 17159822
  99. [106]Drew PD Chavis JA Female sex steroids: effects upon microglial cell activation J Neuroimmunol 2000 111 1–2 77 85 11063824
  100. [107]Baker AE Brautigam VM Watters JJ Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta Endocrinology 2004 145 11 5021 5032 15256495
  101. [108]Brait VH Jackman KA Walduck AK Selemidis S Diep H Mast AE Guida E Broughton BR Drummond GR Sobey CG Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide J Cereb Blood Flow Metab 2010 30 7 1306 1317 20145655 PMC2949221
  102. [109]Johann S Beyer C Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia J Steroid Biochem Mol Biol 2013 137 1 39 45 23196064
  103. [110]Wood H Neuroimmunology: estrogen receptor ligands suppress inflammatory responses in astrocytes and microglia Nat Rev Neurol 2011 7 7 355 21691333
  104. [111]Crain JM Watters JJ Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection Open Drug Discov J 2010 2 148 167 21961028 PMC3180920
  105. [112]Dang J Mitkari B Kipp M Beyer C Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats Brain Behav Immun 2011 25 4 715 726 21277368
  106. [113]McCullough LD Zeng Z Blizzard KK Debchoudhury I Hurn PD Ischemic nitric oxide and poly (ADP-ribose) polymerase- 1 in cerebral ischemia: male toxicity, female protection J Cereb Blood Flow Metab 2005 25 4 502 512 15689952
  107. [114]Li J McCullough LD Sex differences in minocycline-induced neuroprotection after experimental stroke J Cereb Blood Flow Metab 2009 29 4 670 674 19190654 PMC2855881
  108. [115]Hagberg H Wilson MA Matsushita H Zhu C Lange M Gustavsson M Poitras MF Dawson TM Dawson VL Northington F Johnston MV PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury J Neurochem 2004 90 5 1068 1075 15312162
  109. [116]Liu F Lang J Li J Benashski SE Siegel M Xu Y McCullough LD Sex differences in the response to poly(ADP-ribose) polymerase-1 deletion and caspase inhibition after stroke Stroke 2011 42 4 1090 1096 21311064 PMC3066270
  110. [118]Mabley JG Horvath EM Murthy KG Zsengeller Z Vaslin A Benko R Kollai M Szabo C Gender differences in the endotoxin- induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation J Pharmacol Exp Ther 2005 315 2 812 820 16079296
  111. [120]Carson MJ Bilousova TV Puntambekar SS Melchior B Doose JM Ethell IM A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease Neurotherapeutics 2007 4 4 571 579 17920538 PMC2637868
  112. [121]Michelucci A Heurtaux T Grandbarbe L Morga E Heuschling P Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta J Neuroimmunol 2009 210 1–2 3 12 19269040
  113. [122]Sica A Mantovani A Macrophage plasticity and polarization: in vivo veritas J Clin Invest 2012 122 3 787 795 22378047 PMC3287223
  114. [123]Hu X Li P Guo Y Wang H Leak RK Chen S Gao Y Chen J Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia Stroke 2012 43 11 3063 3070 22933588
  115. [124]Belmadani A Tran PB Ren D Miller RJ Chemokines regulate the migration of neural progenitors to sites of neuroinflammation J Neurosci 2006 26 12 3182 3191 16554469 PMC2740990
  116. [125]Eyo UB Dailey ME Microglia: Key Elements in Neural Development, Plasticity, and Pathology J Neuroimmune Pharmacol 2013 8 3 494 509 23354784 PMC3657325
  117. [126]Madinier A Bertrand N Mossiat C Prigent-Tessier A Beley A Marie C Garnier P Microglial involvement in neuroplastic changes following focal brain ischemia in rats PLoS One 2009 4 12 e8101 19956568 PMC2779656
  118. [127]Zhao BQ Wang S Kim HY Storrie H Rosen BR Mooney DJ Wang X Lo EH Role of matrix metalloproteinases in delayed cortical responses after stroke Nat Med 2006 12 4 441 445 16565723
  119. [128]Fox C Dingman A Derugin N Wendland MF Manabat C Ji S Ferriero DM Vexler ZS Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion J Cereb Blood Flow Metab 2005 25 9 1138 1149 15874975 PMC2262097
  120. [129]Chu LS Fang SH Zhou Y Yu GL Wang ML Zhang WP Wei EQ Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats Acta Pharmacol Sin 2007 28 6 763 772 17506934
  121. [130]Carty ML Wixey JA Colditz PB Buller KM Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens Int J Dev Neurosci 2008 26 5 477 485 18387771
  122. [131]Hayakawa K Irie K Sano K Watanabe T Higuchi S Enoki M Nakano T Harada K Ishikane S Ikeda T Fujioka M Orito K Iwasaki K Mishima K Fujiwara M Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanism Biol Pharm Bull 2009 32 9 1538 1544 19721229
  123. [132]Xuan A Long D Li J Ji W Hong L Zhang M Zhang W Neuroprotective effects of valproic acid following transient global ischemia in rats Life Sci 2012 90 11–12 463 468 22285595

Cited by

Sorted by citations

Authors
Chen, Y., Won, S. J., Xu, Y., & Swanson, R. A.
Venue
Current Medicinal Chemistry
Publisher
Bentham Science Publishers Ltd.
Published
2014-04
Volume
21
Issue
19
Pages
2146-2155
ISSN
0929-8673
DOI
10.2174/0929867321666131228203906
PMC
PMC4076056
Cited by
74
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review